Search

everythinglearnresearchcommunity

for

Search:↓

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Certain genetic variants may increase the risk of developing PCOS.

Losartan can cause temporary loss of taste.

Losartan may help treat Postural Orthostatic Tachycardia Syndrome (POTS) symptoms.

Wnt signaling is essential for forming the skin's spinous layer through a BMP-FGF pathway.

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

Finasteride safely treats enlarged prostate and male-pattern baldness.

People in Jeddah know about Vitamin D and its sources but are unclear on how much they need daily, and while many women take supplements, attitudes towards increasing Vitamin D levels vary.

Diuretics can cause serious side effects and should be used carefully.

Microneedles combined with light therapy can improve skin disease diagnosis and treatment.

Microneedle patches improve drug delivery for skin treatments and cosmetic enhancements.

Pranlukast and mirabegron may work as new diabetes drugs.

The review explains how hair products work and the science of different hair types to help improve hair care research.

Some blood pressure medications are linked to a higher risk of skin cancer.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Lisinopril, a heart medication, probably caused hair loss in a patient, which stopped after switching drugs.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Adding baricitinib will increase costs but offers more treatment options for alopecia areata.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.